We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Prognostic Value of Specific Biomarker in Prostate Cancer Authenticated

By LabMedica International staff writers
Posted on 20 Aug 2019
Print article
Image: The VS110 combines microscopy seamlessly with imaging to create a virtual slide that is an exact copy of the real specimen (Photo courtesy of Olympus).
Image: The VS110 combines microscopy seamlessly with imaging to create a virtual slide that is an exact copy of the real specimen (Photo courtesy of Olympus).
Prostate cancer (PC) is the most commonly diagnosed cancer in Canadian men. In men with high-risk PC, progression of the disease will lead to biochemical recurrence (BCR), distant metastases, and disease-specific mortality.

The extensively studied nuclear factor kappa B (NF-κB) pathway is involved in the regulation of inflammation and the immune response, and more recently demonstrated its importance in cancer development. The activation of the NF-κB signaling pathways can result in the progression of several types of cancer, including PC.

A large team of scientists at the Centre hospitalier de l’Université de Montréal (Montreal, QC, Canada) and their associates accessed two different multi-center tissue microarrays (TMAs) representing cohorts of patients (Test-TMA and Validation-TMA series) of the Canadian Prostate Cancer Biomarker Network (CPCBN) to validate the association between p65 nuclear frequency and PC outcomes. Immunohistochemical staining of p65 was performed on the Test-TMA and Validation-TMA series, which include PC tissues from patients treated by first-line radical prostatectomy (n = 250 and n = 1,262, respectively).

For each patient, 0.6-mm cores (3–4 of tumor tissue and 1–2 of benign adjacent tissue) were punctured from formalin-fixed paraffin-embedded blocks and transferred to receiver blocks. Four-micrometer-thick sections of each TMA block were subjected to antigen retrieval in Cell Conditioning 1 for 90 minutes and then stained using the BenchMark XT autostainer. All sections were scanned using a VS-110 microscope with a 20× 0.75 NA objective and a resolution of 0.3225 μm. Two independent observers evaluated the p65 nuclear frequency in digital images of cancer tissue and benign adjacent gland tissue.

Multivariate analysis of the Validation-TMA cohort showed that p65 nuclear frequency in cancer cells was an independent predictor of BCR using continuous (hazard ratio [HR] 1.02) and dichotomized data (HR 1.33). The team used a cutoff of 3%, and found that this biomarker was also associated with the development of bone metastases (HR 1.82) and PC-specific mortality (HR 2.63), independent of clinical parameters. BCR-free survival, bone-metastasis-free survival, and PC-specific survival were shorter for patients with higher p65 nuclear frequency.

The authors concluded that they had demonstrated the prognostic significance of nuclear p65 in two independent PC TMA cohorts that included primary tumor tissues of patients from multiple institutions. The implementation of this biomarker in the clinical workflow would allow genitourinary pathologists and clinicians to improve the identification of patients with high-risk PC. The study was published on July 2, 2019, in the journal PLOS Medicine.

Related Links:
Centre hospitalier de l’Université de Montréal

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
ACTH Assay
ACTH ELISA
New
Auto Clinical Chemistry Analyzer
cobas c 703

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.